AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacsus 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Biovalence Skin Care

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacsus 0.03% Ointment

Atopic dermatitis (eczema) is treated with Tacsus 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Tacsus 0.03% Ointment topically 2–4 times daily to affected skin, or as directed by your physician. Gently and evenly rub it in. Avoid overuse and do not bandage or cover the treated area. Consult your doctor if no improvement is seen after two weeks or if your skin condition worsens. Common side effects may include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally discouraged unless absolutely necessary.

Primary Ingredients of Tacsus 0.03% Ointment

No text provided to rephrase.

Uses of Tacsus 0.03% Ointment

Managing atopic dermatitis

Major Benefits of Tacsus 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected skin is clean and dry before carefully rubbing in the ointment.

Common Side effects of Tacsus 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacsus 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Ensure the affected skin is clean and dry before carefully rubbing in the ointment.

How Tacsus 0.03% Ointment works:

Tacsus 0.03% Ointment, an immunosuppressant topical medication, reduces skin inflammation—manifested as redness and swelling—by modulating the activity of specific immune cells. This action alleviates itching and improves atopic dermatitis rashes.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tacsus 0.03% Ointment during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Application of Tacsus 0.03% Ointment while breastfeeding appears to pose minimal risk. Available human data indicate insignificant infant exposure to the medication.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No drug interaction identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacsus 0.03% Ointment :

Should you forget a Tacsus 0.03% Ointment application, use it at your earliest convenience. If your next scheduled application is imminent, however, omit the missed dose and resume your normal dosing regimen.

Facts to Know About Tacsus 0.03% Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Medication Classification Cancer treatments
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitors

FAQs on Tacsus 0.03% Ointment

Tacsus 0.03% Ointment is an immunomodulatory medication that primarily reduces immune system activity. This ointment treats moderate to severe adult eczema (atopic dermatitis) in patients unresponsive to steroids or experiencing steroid-related adverse effects. Atopic dermatitis involves an overactive skin immune response, resulting in inflammation, itching, redness, and dryness. Tacsus 0.03% Ointment modifies this aberrant immune response, alleviating inflammation and itching.
Topical application of Tacsus 0.03% Ointment can induce localized skin reactions. These may include mild to moderate irritation, burning, and itching, typically resolving within a week. Redness, warmth, pain, altered sensation, and rash are also possible. Treatment use is associated with a heightened risk of folliculitis, cold sores, acne breakouts, and disseminated herpes simplex.
Tacsus 0.03% Ointment offers a safe and effective short-term topical treatment for atopic dermatitis, exhibiting superior safety compared to other immunosuppressant medications. Its minimal systemic absorption following cutaneous application results in fewer adverse effects than oral immunosuppressants.
Tacsus 0.03% Ointment is not a controlled substance and poses no risk of misuse. Controlled substances, by definition, have a potential for abuse, requiring authorization from both medical professionals and regulatory bodies.
Prolonged application of Tacsus 0.03% Ointment is associated with a heightened lymphoma risk (a type of lymph node tumor). Limited research indicates a link between Tacsus 0.03% Ointment, or comparable treatments, and the development of skin cancer or lymphoma in a small number of patients. Seek medical advice if Tacsus 0.03% Ointment use exceeds six weeks, or if your eczema symptoms fail to improve or worsen during treatment.
Tacsus 0.03% Ointment is non-steroidal. This medication modifies immune system function and treats eczema, particularly atopic dermatitis. A key benefit is its lack of skin thinning (atrophy) or other adverse effects typically associated with steroids.
Tacsus 0.03% Ointment
107
MRP 130
17% off